Design of Surface-Modified Electrodes for the Electrochemical Adsorption of Platinum-Based Anticancer Drugs
Source abstract
Abstract
The design of a hemofiltration method that minimizes the side effects produced by the accumulation of Pt-based drugs such as cisplatin represents an important technology for cancer treatment. This work establishes the foundation for the development of an efficient platform for the electrochemical hemofiltration and simultaneous sensing of antitumor drugs, such as cisplatin and carboplatin, from physiological medium. The electrochemical filtration system is based on a gold surface-modified electrode using tris(carboxyethyl)phosphine ligands as scavengers of the Pt-based drug complexes. The platinum–phosphine interaction is shown to be more time efficient, as compared to the naturally occurring form of a glutathione–platinum adduct, and displayed a highly cooperative nature of binding. Altogether, we demonstrate that the presence of ligands capable of binding to Pt results in a differential spectroscopic and electrochemical response and the potential to adsorb and monitor the concentration of Pt salts in complex aqueous media.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Molecular Junctions and Nanostructures · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Chemistry and Biochemistry, Freire Universität Berlin, Takustr.3, 14195 Berlin, Germany
Department of Physics, University of Warwick, CV4 7AL Coventry, U.K.
School of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, U.K.
Funding
Wellcome Trust · University of Birmingham
References (37)
Show source-provided references
1. 10.1038/205698a010.1038/205698a0 ↗
2. 10.1038/222385a010.1038/222385a0 ↗
3. 10.1021/cr980420v10.1021/cr980420v ↗
4. 10.2165/00003495-199346030-0000310.2165/00003495-199346030-00003 ↗
5. 10.1038/nrc216710.1038/nrc2167 ↗
6. 10.1038/bjc.1993.22110.1038/bjc.1993.221 ↗
7. Von Hoff D. D. · Cancer Treat. Rep. · 1979 · 63 · 1527
8. 10.3390/cancers301135110.3390/cancers3011351 ↗
9. 10.1200/JCO.2005.00.92710.1200/JCO.2005.00.927 ↗
10. Yatzidis, H. A convenient haemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxications. Its use as an effective artificial kidney, Proceeding of the European Dialysis and Transplant Association, 1964; pp 83–87.
11. 10.1111/j.0954-6820.1966.tb02875.x10.1111/j.0954-6820.1966.tb02875.x ↗
12. Webb D. · Br. J. Hosp. Med. · 1993 · 49 · 493
13. 10.1007/BF0289720110.1007/BF02897201 ↗
14. 10.1021/ja309857d10.1021/ja309857d ↗
15. 10.1021/jm900138u10.1021/jm900138u ↗
16. 10.1021/ic00190a01710.1021/ic00190a017 ↗
17. 10.1016/j.electacta.2017.07.13610.1016/j.electacta.2017.07.136 ↗
18. 10.1016/0143-148X(80)90017-810.1016/0143-148X(80)90017-8 ↗
19. 10.1039/c2cc38517a10.1039/c2cc38517a ↗
20. 10.1016/0022-0728(95)04283-010.1016/0022-0728(95)04283-0 ↗
21. 10.1021/ja002393810.1021/ja0023938 ↗
22. 10.1039/jr955000445610.1039/jr9550004456 ↗
23. Hill A. V. · J. Physiol. · 1910 · 40 · 4
24. 10.1021/ic00229a00510.1021/ic00229a005 ↗
25. 10.1021/ic00136a00510.1021/ic00136a005 ↗
26. 10.1002/anie.19870693110.1002/anie.198706931 ↗
27. 10.1002/cber.1996129090210.1002/cber.19961290902 ↗
28. 10.1016/j.jelechem.2017.07.03910.1016/j.jelechem.2017.07.039 ↗
29. 10.1039/b416831c10.1039/b416831c ↗
30. 10.1021/la020806810.1021/la0208068 ↗
31. 10.1016/S0022-0728(97)00006-510.1016/S0022-0728(97)00006-5 ↗
32. 10.1021/la991328c10.1021/la991328c ↗
33. 10.1021/jp000151o10.1021/jp000151o ↗
34. 10.1016/j.surfcoat.2006.07.26410.1016/j.surfcoat.2006.07.264 ↗
35. 10.1021/la047860410.1021/la0478604 ↗
36. 10.1016/0013-4686(83)85163-910.1016/0013-4686(83)85163-9 ↗
37. 10.1149/1.139171310.1149/1.1391713 ↗